Today: 21 May 2026
Reckitt Benckiser share price dips as CEO and CFO add stock via dividend reinvestment plan
24 February 2026
1 min read

Reckitt Benckiser share price dips as CEO and CFO add stock via dividend reinvestment plan

London, February 24, 2026, 08:50 GMT — Regular session

  • Reckitt Benckiser shares dipped roughly 0.3% at the start of London trading.
  • CEO Kris Licht and CFO Shannon Eisenhardt picked up shares through a dividend reinvestment plan, a filing shows.
  • European shares slipped as tariff questions hung in the air; Reckitt holders now eyeing results due in early March.

Reckitt Benckiser Group plc slipped 0.3% in early London hours on Tuesday, off by 16 pence at 6,382 as of 0847 GMT. So far, the shares have moved between 6,370 and 6,432. That leaves the price roughly 2% under the 52-week high of 6,514 pence.

That change wasn’t dramatic, yet attention swung back to management after a directors’ dealing notice, especially with the company’s next results update coming up in early March.

European stocks edged lower Tuesday, with investors holding back as fresh U.S. tariffs loomed. Bank shares lagged—jitters over AI disrupting legacy business models resurfaced, putting additional pressure on the sector, Reuters said.

According to a filing posted late Monday, chief executive Kris Licht picked up 2,109 ordinary shares at £64.61933 apiece on Feb. 20, while finance chief Shannon Eisenhardt took 189 shares at that price. Both transactions ran through the company’s dividend reinvestment plan, the filing said.

Dividend reinvestment plans give shareholders the option to take their payout as new shares, typically via a broker’s programme. These purchases may look routine, yet traders pay attention if they pop up near an earnings release.

Reckitt’s lineup covers hygiene, health and nutrition, featuring brands such as Lysol, Finish and Air Wick on the hygiene side, and Dettol, Durex, Nurofen in health, per a Reuters company profile.

Macro jitters haven’t let up. “Uncertainty remains high,” said Mark Hackett, chief market strategist at Nationwide, on Monday, with investors weighing who stands to gain or lose as U.S. trade policy keeps evolving. Reuters

Reckitt’s next update won’t hinge on minor insider trades; investors want management’s take on volume trends, pricing, and margins. The market is tuning in for concrete guidance on what’s coming this year.

The most recent insider buying came from dividend reinvestments, not new open-market buys, and amounts were on the small side. Should risk sentiment deteriorate, the stock could end up moving in step with the broader market rather than reacting to its specific headlines.

Reckitt is set to release its full-year results on March 5, with an investor presentation scheduled for 0830 GMT at the London Stock Exchange, the company announced.

Stock Market Today

  • Scotiabank Shares Showing 32% Undervaluation at C$108 Amid Strong Returns
    May 20, 2026, 10:05 PM EDT. Scotiabank (TSX:BNS) stock has rallied to around C$108.50, delivering a 59.4% return over the past year and nearly 79% over five years highlighting strong performance. Despite this, valuation models suggest substantial remaining upside. Simply Wall St's Excess Returns analysis estimates the bank's intrinsic value at approximately C$160 per share, indicating it is 32.2% undervalued compared to current prices. This model calculates excess returns by comparing the bank's return on equity to its cost of equity, reflecting efficient shareholder profit generation. Investors are closely watching key fundamentals including balance sheet resilience and dividend yield as Scotiabank navigates evolving interest rate environments. The stock's valuation score of 4 out of 6 suggests moderate confidence among analysts that price gains can continue.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Previous Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Haleon PLC share price slips ahead of FY 2025 results as investors eye guidance
Next Story

Haleon PLC share price slips ahead of FY 2025 results as investors eye guidance

Go toTop